November 21, 2014

The membership of the Pharmacy Quality Alliance has endorsed a new performance measure, Statin Use in Persons with Diabetes, the group announced Friday. 

November 18, 2014

Dave Wendland, VP and member of the owner’s group at Hamacher Resource Group (HRG), will once again moderate the Diabetes and Chronic Care roundtable at Drug Store News’ Industry Issues Summit on Dec. 3, 2014. This marks Wendland’s 11th  year moderating the event.

November 17, 2014

Four-in-10 U.S. adults are expected to develop Type 2 diabetes at some point in their lifetime, according to a new study published in The Lancet Diabetes & Endocrinology in August, suggesting that as many as 126 million consumers will be looking for treatment options, including self-monitoring their condition at home.

November 11, 2014

In recognition of American Diabetes Month in November, Price Chopper has developed food- and health-related programs to help promote awareness on the issues surrounding diabetes and the people who are impacted by the disease.

November 10, 2014

Eli Lilly and Co. on Monday announced that its Type 2 diabetes treatment drug Trulicity (dulaglutide) , is now available in U.S. pharmacies. The drug is a once-weekly glucagon-like peptide-1 receptor agonist, and comes in a single-dose pen, which doesn't require the patient to mix, measure or handle the needle, the company said.

November 10, 2014

The YMCA of Greater Rochester, Wegmans Pharmacy and the American Diabetes Association will host three events to provide community members with health education about diabetes.

November 5, 2014

Novo Nordisk on Wednesday announced the relaunch of Cornerstones4Care, an online patient support platform for people living with diabetes.

November 4, 2014

In recognition of American Diabetes Month, Colgate Total on Tuesday announced the "Small Steps Make A Big Difference" campaign to help raise awareness surrounding the relationship between oral health and diabetes. 

 

October 31, 2014

Diabetes treatment with a low-cost generic drug can have significant, positive implications for a patient's quality of life and medication cost, according to new research from CVS Health.

October 30, 2014

AstraZeneca on Thursday announced that the Food and Drug Administration approved Xigduo XR (dapagliflozin and metformin hydrochloride extended-release), a once-daily drug for the treatment of adults with Type 2 diabetes. 

October 17, 2014

"The United States is in the midst of a prescription drug abuse epidemic as addiction, overdoses and deaths associated with non-medical drug use have risen dramatically over the last decade. In 2009, U.S. drug overdose deaths outnumbered motor vehicle accident deaths for the first time," writes Wendy Cloe, a director at Emdeon, in her latest blog.

October 15, 2014

Sanofi US announced Wednesday the findings of a new survey that reveals striking differences in opinion among various age groups about diabetes and available treatment options.

October 10, 2014

What retail chain has more stores than any other U.S. company, with plans to open an astonishing 700 new locations this year alone, while approaching $20 billion in revenue and maintaining sales and profit momentum? It¹s Dollar General, the storied Goodlettsville, Tenn.-based small-box discount giant celebrating its 75th year in business. Download this exclusive report.

September 19, 2014

The Food and Drug Administration on Thursday approved Trulicity (dulaglutide), a once-a-week injection to improve blood-sugar levels in adults with Type 2 diabetes. 

September 16, 2014

In this special diabetes report, DSN covers the latest innovation in the diabetes sector from wearable technology to prescription drugs to devices to pharmacist care for diabetic patients.

September 15, 2014

Community pharmacists can dramatically help their patients stick to their prescription regimens, according to a new study led by researchers at the University of Pittsburgh School of Pharmacy. 

September 15, 2014

Among those with diabetes, patient-focused, collaborative care that includes pharmacists can positively impact health outcomes, particularly in underserved or uninsured populations.

September 15, 2014

Close to half (40%) of the U.S. adult population — roughly 126 million — is expected to develop Type 2 diabetes at some point during their lifetime, according to a study published in The Lancet Diabetes and Endocrinology in August.

September 15, 2014

Thanks to the Centers for Medicare and Medicaid Services’ Five-Star Quality Rating System, the diabetes community stands to play a significant role in how pharmacies think about their patients and their medication adherence programs. 

September 15, 2014

Sales of the popular Type 2 diabetes drug metformin may get a boost if physicians begin prescribing the medicine as a prophylactic in people who don’t have diabetes. A recent study published in the diabetes journal Diabetes, Obesity and Metabolism and conducted by scientists from Cardiff University found that patients treated with metformin could live longer than people without diabetes.

September 15, 2014

Dick Tracy has nothing on the wearable gadgets under development to help people better police their diabetes. Wearable technologies in its totality — which include Google Glass and the Apple Watch — are part of a booming market that’s expected to swell to $20 billion by 2015 and is further expected to grow at a compound annual growth rate of nearly 40% over the next six years.

September 9, 2014

AstraZeneca's once-weekly Bydureon (exenatide extended-release for injectable suspension) pen now is available in pharmacies across the United States, the company announced.

September 3, 2014

Abbott on Wednesday announced that it has received CE Mark (Conformite Europeenne) for its FreeStyle Libre Flash Glucose Monitoring System, a revolutionary new glucose-sensing technology for people with diabetes. 

August 27, 2014

"The diabetic is a critically important patient for pharmacies to serve. Yet, with increased Medicare audits, stringent compliance requirements and reduced reimbursements, is servicing these patients really worth it?" writes Kevin Dore, a director at Emdeon, in his latest blog.